DavidWheeler University College LondonUnited Kingdom

DavidWheeler
David C WheelerrDavid is Professor of Kidney Medicine at University College London and Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust. He is a clinical scientist interested in chronic kidney disease (CKD). He has participated in the development and delivery of several large-scale clinical trials testing lipid lowering regimens (SHARP), calcimimetics (EVOLVE), intravenous iron (PIVOTAL), SGLT2 inhibitors (CREDENCE and DAPA-CKD) and HIF stabilisers (ASCEND) in patients with CKD. He was co-chief investigator for the DAPA-CKD study (with Hiddo Lambers Heerspink). David has been involved in the development of Clinical Practice Guidelines for several organisations, most recently for Kidney Disease: Improving Global Outcomes (KDIGO). He served as KDIGO co-chair between 2012 and 2019. Other recent roles include Chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACTs) committee. In the UK, he is National Institute of Health Research (NIHR) Specialty Lead for Renal Disorders.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/4ebc6caaa51e79209f4061cd08dff279.jpg
First Name
David
Last Name
Wheeler
Institution
Country.
United Kingdom

Friday, February 7, 2025

Time Session
2:15 p.m.
3:45 p.m.
Bridging the Clinical Gap: Sustainable Strategies and Innovative Therapies for Global Kidney Health
ErangaWijewickrama Chair Faculty of Medicine, University of ColomboSri Lanka
Prof (Dr ) SanjeevGulati Chair Executive Director Nephrology and Kidney Transplant, Fortis gp of Hospitals and Adjunct Professor, Manipal University India
  • Sustainable Community Approaches to Early CKD Detection
    RonaldGansevoort Speaker Dept. Nephrology, University Medical Center GroningenNetherlands
  • Kidney Disease Treatment Gaps Worldwide - Where Are the Solutions?
    AdeeraLevin Speaker University of British Columbia and Providence Health CareCanada
  • The Promise of Emerging Therapies in Reducing the Global Kidney Disease Burden
    DavidWheeler Speaker University College LondonUnited Kingdom
  • Co-opting Patients as Partners in Kidney Care: How Do We Do It?
    ShilpanjaliJesudason Speaker Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Co-opting Patients as Partners in Kidney Care: How Do We Do It?
    ShyamsundarMuthuramalingam Speaker Central Adelaide Local Health Network Australia
  • Q&A
Kesar Hall 202

Saturday, February 8, 2025

Time Session
2:15 p.m.
3:45 p.m.
What’s Next in Kidney Care Research? Innovations and Clinical Trials on the Horizon
AdeeraLevin Chair University of British Columbia and Providence Health CareCanada
AndreaViecelli Chair University of QueenslandAustralia
Ajit singhNarula Chair India
  • Novel Trial Designs in Nephrology: Innovations and Structures
    MegJardine Speaker NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
  • What’s New in Clinical Trials?
    DavidWheeler Speaker University College LondonUnited Kingdom
  • Value of Different Outcomes in the Era of Precision Medicine
    RobertoPecoits Filho Speaker Arbor Research Collaborative for HealthUnited States
  • Conducting Trials in Low and Middle-income Countries
    SoumitaBagchi Speaker Professor, Department of Nephrology, All India Institute of Medical Sciences, New DelhiIndia
  • Innovations in Pediatric Nephrology Discovery and Clinical Trial Conduct
    ArpanaIyengar Speaker ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALOREIndia
  • Q&A
Parijat Hall 201

Sunday, February 9, 2025

Time Session
9 a.m.
10:30 a.m.
HIT! High Impact Clinical Trials – Why and How
DavidWheeler Chair University College LondonUnited Kingdom
Winston Wing ShingFung Chair Prince of Wales Hospital, Hong KongHong Kong, China
  • What Have We Learned From CONVINCE?
    PeterBlankestijn Oral Abstract Presenter University Medical Center UtrechtNetherlands
  • Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease
    VladoPerkovic Oral Abstract Presenter University of New South Wales, Sydney, AustraliaAustralia
  • A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
    JonathanBarratt Oral Abstract Presenter University of Leicester, Leicester, UKUnited Kingdom
  • Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease
    KateBramham Oral Abstract Presenter King's College LondonUnited Kingdom
  • Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage
    Selvin Sundar RajMani Oral Abstract Presenter Associate Professor in Nephrology, Christian Medical College, Vellore, IndiaIndia
    SuceenaAlexander Oral Abstract Presenter Christian Medical College VelloreIndia
Brahmkamal Hall - Plenary Hall